Systemic Antibiotics for Second- and Third-Degree Burns
Systemic antibiotic prophylaxis is NOT routinely recommended for second- and third-degree burns, as the evidence shows no benefit for most burn patients and may increase antimicrobial resistance. 1, 2, 3
Key Principle: Prophylaxis vs. Treatment
The Surviving Sepsis Campaign explicitly recommends against sustained systemic antimicrobial prophylaxis in patients with burn injury, as these represent severe inflammatory states of noninfectious origin 1. This represents the highest-quality guideline evidence available and should guide practice.
When Systemic Antibiotics ARE Indicated
1. Established Infection with Sepsis/Septic Shock
When burn patients develop documented infection with sepsis or septic shock, immediate empiric broad-spectrum therapy is required 1:
- Initiate within 1 hour of recognition 1
- Empiric regimen must cover likely pathogens including Pseudomonas aeruginosa, Acinetobacter species, and MRSA 1
- Combination therapy recommended for septic shock: extended-spectrum β-lactam (piperacillin-tazobactam, meropenem, or imipenem) PLUS vancomycin for MRSA coverage 1, 4, 5
- Duration: 7-10 days typically, with de-escalation within 3-5 days once susceptibilities known 1
2. Severe Burns Requiring Mechanical Ventilation
The only prophylactic indication with supporting evidence 2, 6:
- Systemic antibiotic prophylaxis for 4-14 days after admission may reduce mortality in severe burns requiring mechanical ventilation 6
- This showed a mortality reduction (RR 0.54,95% CI 0.34-0.87) with number needed to treat of 8 6
- However, this increases antimicrobial resistance (rate ratio 2.84) 6
3. Perioperative Prophylaxis for Skin Grafting
Limited benefit in selected procedures 2:
- May prevent split-thickness skin graft infections in selected procedures only 2
- NOT beneficial for most burn patients undergoing debridement 2
- Insufficient evidence for extensive burns 4
What NOT to Do
Avoid Routine Prophylaxis
- No benefit for preventing toxic shock syndrome in low-severity burns 7, 2
- No benefit for preventing burn wound infection 2, 3
- Silver sulfadiazine (topical) actually increases burn wound infection rates (OR 1.87) and hospital stay 3
Avoid Prolonged Prophylaxis
- Long-term systemic prophylaxis shows no effectiveness in preventing wound infection 7, 2, 3
- Significantly increases antimicrobial resistance 6
Empiric Regimens When Treatment IS Required
For Documented Infection (Non-Septic)
Monitor closely; mild infections in stable patients may not require immediate antibiotics 7
For Sepsis/Septic Shock
- Vancomycin 30 mg/kg/day IV in 2 divided doses (adults) PLUS
- Piperacillin-tazobactam 3.37 g IV every 6-8 hours, OR
- Meropenem 1 g IV every 8 hours, OR
- Imipenem-cilastatin 1 g IV every 6-8 hours
Pediatric dosing 4:
- Vancomycin 15 mg/kg/dose IV every 6 hours
- Piperacillin-tazobactam 60-75 mg/kg/dose (piperacillin component) every 6 hours
For Suspected Pseudomonas
Combination therapy with β-lactam plus aminoglycoside or fluoroquinolone for bacteremia 1
Critical Pitfalls to Avoid
- Do not give prophylactic antibiotics for uncomplicated second- or third-degree burns without mechanical ventilation 1, 2
- Do not continue empiric therapy beyond 3-5 days without documented infection 1
- Do not use silver sulfadiazine as it worsens outcomes 3
- Do not delay source control (surgical debridement) while relying on antibiotics 4, 5
Special Considerations
Necrotizing infection: If necrotizing fasciitis develops, urgent surgical debridement is primary therapy, with antibiotics as adjunct using regimens covering aerobes, anaerobes, and MRSA 4, 5
Resistance concerns: The evidence consistently shows that prophylactic antibiotic use in burns increases resistance to the prophylactic agent used 6, making judicious use essential.